A SENSITIVE AND SPECIFIC LIQUID-CHROMATOGRAPHIC ASSAY FOR DETERMINATION OF GANCICLOVIR IN PLASMA AND URINE AND ITS APPLICATION TO PHARMACOKINETIC STUDIES IN THE RABBIT

被引:17
作者
HEDAYA, MA [1 ]
SAWCHUK, RJ [1 ]
机构
[1] UNIV MINNESOTA,COLL PHARM,DEPT PHARMACEUT,MINNEAPOLIS,MN 55455
关键词
analysis; ganciclovir; pharmacokinetics; rabbit model; renal secretion;
D O I
10.1023/A:1015920023272
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A liquid-chromatographic assay for the analysis of ganciclovir in plasma and urine is described. This assay involves the use of acyclovir, an antiviral drug structurally related to ganciclovir, as the internal standard. A two-step sample preparation method is used. After protein is precipitated with acetonitrile and the addition of diethyl ether, ganciclovir and the internal standard are back extracted into a small volume of aqueous ammonium phosphate, taking advantage of their relatively high water solubility. This isocratic method is specific and sufficiently sensitive to allow quantification of ganciclovir throughout the entire range of concentrations observed during therapeutic use of this antiviral drug. There was no interference from various over-the-counter and prescription drugs often prescribed to patients most likely to receive ganciclovir therapy. This assay was used to analyze plasma and urine samples obtained after intravenous administration of ganciclovir to rabbits. Biexponential decay of ganciclovir plasma concentration–time and urinary excretion rate–time profiles was observed, with a mean distribution half-life of 15.8 min and an elimination half-life of 96 min. The mean renal clearance, 9.0 ml/min per kg, exceeds the glomerular filtration rate in the rabbit, indicating that ganciclovir is actively secreted in the renal tubule. Similar results were obtained by determining the renal clearance at steady state during constant-rate intravenous infusion of ganciclovir. © 1990, Plenum Publishing Corporation. All rights reserved.
引用
收藏
页码:1113 / 1118
页数:6
相关论文
共 17 条
[1]   UNIQUE SPECTRUM OF ACTIVITY OF 9-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]-GUANINE AGAINST HERPESVIRUSES INVITRO AND ITS MODE OF ACTION AGAINST HERPES-SIMPLEX VIRUS TYPE-1 [J].
CHENG, YC ;
HUANG, ES ;
LIN, JC ;
MAR, EC ;
PAGANO, JS ;
DUTSCHMAN, GE ;
GRILL, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09) :2767-2770
[2]   GANCICLOVIR TREATMENT OF CYTOMEGALOVIRUS DISEASE IN TRANSPLANT RECIPIENTS AND OTHER IMMUNOCOMPROMISED HOSTS [J].
ERICE, A ;
JORDAN, C ;
CHACE, BA ;
FLETCHER, C ;
CHINNOCK, BJ ;
BALFOUR, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (22) :3082-3087
[3]   HUMAN PHARMACOKINETICS OF THE ANTIVIRAL DRUG DHPG [J].
FLETCHER, C ;
SAWCHUK, R ;
CHINNOCK, B ;
DEMIRANDA, P ;
BALFOUR, HH .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) :281-286
[4]   ACTIVITY OF 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE COMPARED WITH THAT OF ACYCLOVIR AGAINST HUMAN, MONKEY, AND RODENT CYTOMEGALOVIRUSES [J].
FREITAS, VR ;
SMEE, DF ;
CHERNOW, M ;
BOEHME, R ;
MATTHEWS, TR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (02) :240-245
[5]   EFFICACY AND SAFETY OF 2 DIFFERENT DOSE LEVELS OF GANCICLOVIR FOR THE TREATMENT OF CYTOMEGALO-VIRUS CHORIORETINITIS IN AIDS PATIENTS [J].
GAUB, J ;
POULSEN, AG ;
PEDERSEN, C ;
TINNING, S ;
HOJGAARD, K ;
THOMSON, MH ;
FABER, V ;
NIELSEN, JO .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1988, 20 (05) :479-482
[6]  
Gibaldi M, 1982, PHARMACOKINETICS REV, V2nd, P45
[7]   GANCICLOVIR PHARMACOKINETICS DURING RENAL IMPAIRMENT [J].
LAKE, KD ;
FLETCHER, CV ;
LOVE, KR ;
BROWN, DC ;
JOYCE, LD ;
PRITZKER, MR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (12) :1899-1900
[8]   GANCICLOVIR FOR THE TREATMENT AND SUPPRESSION OF SERIOUS INFECTIONS CAUSED BY CYTOMEGALOVIRUS [J].
LASKIN, OL ;
CEDERBERG, DM ;
MILLS, J ;
ERON, LJ ;
MILDVAN, D ;
SPECTOR, SA .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (02) :201-207
[9]   EFFECT OF 9-(1,3-DIHYDROXY-2-PROPOXYMETHYL)GUANINE ON HUMAN CYTOMEGALOVIRUS REPLICATION INVITRO [J].
MAR, EC ;
CHENG, YC ;
HUANG, ES .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :518-521
[10]   9-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]GUANINE - A NEW POTENT AND SELECTIVE ANTIHERPES AGENT [J].
MARTIN, JC ;
DVORAK, CA ;
SMEE, DF ;
MATTHEWS, TR ;
VERHEYDEN, JPH .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (05) :759-761